NCT04357600Enrolling by invitationPhase 1/2
Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B
Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B: Phase I/ II Study
Source: ClinicalTrials.gov · Last updated 25 Feb 2026
Brief summary (registry, in English)
The study aims to evaluate the effect of allogeneic mesenchymal stem cell therapy on patients who suffered from liver cirrhosis caused by Hepatitis B.
- Status (registry)
- Enrolling by invitation
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- First submitted
- 8 Mar 2020
- Start date
- 17 May 2018
- Primary completion date
- 20 Jun 2027
- Lead sponsor
- PT. Prodia Stem Cell Indonesia
- Diseases
- Hepatitis B
- NCT number
- NCT04357600
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 12
- From 17 May 2018 to the primary completion date, 20 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have undergone transplantation and other stem cell therapy
Other illness
- Having malignancies disease, both liver malignancies or other malignancies
- Having another co-infections such as hepatitis C and Human Immunodeficiency Virus (HIV).
- Having complications disease such as diabetes mellitus, severe heart disease, kidney disease, and respiratory disease
Other
- Patients who refuse to participate in research
- Pregnant or lactation patients as evidenced by positive pregnancy test results
- Having the case of alcohol dependence and NASH
Who the study is looking for
- Patients with decompensated cirrhosis (Child-Pugh B) caused by hepatitis B infection (Cirrhosis is evidenced by the results of ultrasonography examination and chronic hepatitis B infection is found in patients who are taking hepatitis B drugs)
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cipto Mangunkusumo hospital Coordinator of this site? Confirm its status | Jakarta | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.